Get started

More results...

Filter by Content types
Filter by Geography

Alerts LATEST ALERTS

  • Germany Cabinet approves medical cannabis draft bill on telemedicine ...
  • Michigan - United States New budget law includes heavy tax on adult-use cannabis, industry files suit ...
  • Spain Medical cannabis approved by Council of Ministers ...
  • Brazil Anvisa authorises new cannabis-based product for sale ...
  • Czech Republic Change in government could see stricter measures for cannabis ...
  • Lithuania Court to investigate legality of narcotic substances list ...
  • California - United States Governor signs bill into law that significantly restricts hemp product sales ...
  • Germany Bill to ban online medical cannabis prescriptions notified via TRIS ...
  • Poland Government will not decriminalise cannabis ...
  • Brazil Extension requested to deadline on regulating medical cannabis ...
  • Uruguay MSP and IRCCA announce plans to update cannabis regulations ...
  • Germany BLE rejects Frankfurt's adult-use cannabis pilot project application ...
News analysis

Cannabis companies team up with pharma firm to supply Europe

Written by || 14th February 2019 || News analysis | Companies | GeographiesCanada Europe Greece North America Poland United States

Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
*

I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
*

Sign up to our newsletter

Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.